273 related articles for article (PubMed ID: 31514298)
1. Zeaxanthin: Metabolism, Properties, and Antioxidant Protection of Eyes, Heart, Liver, and Skin.
Murillo AG; Hu S; Fernandez ML
Antioxidants (Basel); 2019 Sep; 8(9):. PubMed ID: 31514298
[TBL] [Abstract][Full Text] [Related]
2. Lutein and Zeaxanthin and Their Roles in Age-Related Macular Degeneration-Neurodegenerative Disease.
Mrowicka M; Mrowicki J; Kucharska E; Majsterek I
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215476
[TBL] [Abstract][Full Text] [Related]
3. Macular zeaxanthins and lutein -- a review of dietary sources and bioavailability and some relationships with macular pigment optical density and age-related macular disease.
Thurnham DI
Nutr Res Rev; 2007 Dec; 20(2):163-79. PubMed ID: 19079868
[TBL] [Abstract][Full Text] [Related]
4. Modulatory Effect of Carotenoid Supplement Constituting Lutein and Zeaxanthin (10:1) on Anti-oxidant Enzymes and Macular Pigments Level in Rats.
Madhavan J; Chandrasekharan S; Priya MK; Godavarthi A
Pharmacogn Mag; 2018; 14(54):268-274. PubMed ID: 29720843
[TBL] [Abstract][Full Text] [Related]
5. Effect of dietary zeaxanthin on tissue distribution of zeaxanthin and lutein in quail.
Toyoda Y; Thomson LR; Langner A; Craft NE; Garnett KM; Nichols CR; Cheng KM; Dorey CK
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1210-21. PubMed ID: 11923268
[TBL] [Abstract][Full Text] [Related]
6. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Age-Related Eye Disease Study 2 Research Group
JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
[TBL] [Abstract][Full Text] [Related]
7. Retinal accumulation of zeaxanthin, lutein, and β-carotene in mice deficient in carotenoid cleavage enzymes.
Li B; Vachali PP; Shen Z; Gorusupudi A; Nelson K; Besch BM; Bartschi A; Longo S; Mattinson T; Shihab S; Polyakov NE; Suntsova LP; Dushkin AV; Bernstein PS
Exp Eye Res; 2017 Jun; 159():123-131. PubMed ID: 28286282
[TBL] [Abstract][Full Text] [Related]
8. Transport and retinal capture of lutein and zeaxanthin with reference to age-related macular degeneration.
Loane E; Nolan JM; O'Donovan O; Bhosale P; Bernstein PS; Beatty S
Surv Ophthalmol; 2008; 53(1):68-81. PubMed ID: 18191658
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of selective delivery of xanthophylls to retinal pigment epithelial cells by human lipoproteins.
Thomas SE; Harrison EH
J Lipid Res; 2016 Oct; 57(10):1865-1878. PubMed ID: 27538825
[TBL] [Abstract][Full Text] [Related]
10. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients.
Bernstein PS; Zhao DY; Wintch SW; Ermakov IV; McClane RW; Gellermann W
Ophthalmology; 2002 Oct; 109(10):1780-7. PubMed ID: 12359594
[TBL] [Abstract][Full Text] [Related]
11. Management of Ocular Diseases Using Lutein and Zeaxanthin: What Have We Learned from Experimental Animal Studies?
Xue C; Rosen R; Jordan A; Hu DN
J Ophthalmol; 2015; 2015():523027. PubMed ID: 26617995
[TBL] [Abstract][Full Text] [Related]
12. Xanthophyll: Health benefits and therapeutic insights.
Aziz E; Batool R; Akhtar W; Rehman S; Shahzad T; Malik A; Shariati MA; Laishevtcev A; Plygun S; Heydari M; Rauf A; Ahmed Arif S
Life Sci; 2020 Jan; 240():117104. PubMed ID: 31783054
[TBL] [Abstract][Full Text] [Related]
13. Macular pigment in retinal health and disease.
Lima VC; Rosen RB; Farah M
Int J Retina Vitreous; 2016; 2():19. PubMed ID: 27847637
[TBL] [Abstract][Full Text] [Related]
14. Serum and macular response to carotenoid-enriched egg supplementation in human subjects: the Egg Xanthophyll Intervention clinical Trial (EXIT).
Kelly D; Nolan JM; Howard AN; Stack J; Akuffo KO; Moran R; Thurnham DI; Dennison J; Meagher KA; Beatty S
Br J Nutr; 2017 Jan; 117(1):108-123. PubMed ID: 28122649
[TBL] [Abstract][Full Text] [Related]
15. Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina.
Rapp LM; Maple SS; Choi JH
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1200-9. PubMed ID: 10752961
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Evans JR; Lawrenson JG
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD000254. PubMed ID: 28756618
[TBL] [Abstract][Full Text] [Related]
17. Why is Zeaxanthin the Most Concentrated Xanthophyll in the Central Fovea?
Widomska J; SanGiovanni JP; Subczynski WK
Nutrients; 2020 May; 12(5):. PubMed ID: 32392888
[TBL] [Abstract][Full Text] [Related]
18. Factors Differentiating the Antioxidant Activity of Macular Xanthophylls in the Human Eye Retina.
Widomska J; Gruszecki WI; Subczynski WK
Antioxidants (Basel); 2021 Apr; 10(4):. PubMed ID: 33919673
[TBL] [Abstract][Full Text] [Related]
19. Lutein, zeaxanthin and meso-zeaxanthin content of eggs laid by hens supplemented with free and esterified xanthophylls.
Nolan JM; Meagher KA; Howard AN; Moran R; Thurnham DI; Beatty S
J Nutr Sci; 2016; 5():e1. PubMed ID: 26793307
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Antioxidant Properties of Dehydrolutein with Lutein and Zeaxanthin, and their Effects on Cultured Retinal Pigment Epithelial Cells.
Różanowska MB; Czuba-Pelech B; Landrum JT; Różanowski B
Antioxidants (Basel); 2021 May; 10(5):. PubMed ID: 34068492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
